MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Safinamide reduces membrane excitability and synaptic transmission of striatal spiny projection neurons in a rat model of Parkinson’s disease

    A. Tozzi, M. Sciaccaluga, P. Mazzocchetti, G. Bastioli, V. Ghiglieri, B. Picconi, C. Caccia, C. Keywood, G. Padoani, P. Calabresi (Perugia, Italy)

    Objective: The effect of safinamide (saf) on the electrical membrane properties and both excitatory and inhibitory synaptic transmission of striatal spiny projection neurons (SPNs) was…
  • 2019 International Congress

    Somatization disorder (SD) and Parkinson’s Disease (PD) in Mexican population

    M. Rodriguez-Violante, A. Cervantes-Arriaga, A. Polo-Morales, A. Alcocer-Salas (Ciudad de México, Mexico)

    Objective: Identify, in Mexican patients with PD, the prevalence of SD as well as its impact on cognitive and motor impairment. Background: SD refers to…
  • 2019 International Congress

    Predictive Factors for Depression in a Multicentric Parkinson’s Disease Mexican Cohort

    A. Banegas-Lagos, A. Cervantes-Arriaga, D. Garza-Brambila, E. Garcia-Berlanga, K. Salinas-Barboza, S. Isais-Millan, A. Anaya-Escamilla, E. Velazquez-Avila, G. Parra, A. Gonzalez-Cantú, M. Rodriguez-Violante, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To identify predictive factors for depression in a multicentric Parkinson’s disease (PD) mexican cohort. Background: Depression is a common symptom of PD with a…
  • 2019 International Congress

    The role of dysfunctional attentional processing in isolated minor hallucinations in Parkinson’s disease

    H. Bejr-Kasem, J. Pagonabarraga, S. Martínez-Horta, F. Ruiz-Martínez, F. Bernasconi, F. Sampedro, J. Marín-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, B. Pascual-Sedano, O. Blanke, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore attentional processing deficits in Parkinson's disease (PD) with minor hallucinations using a selective visual attention task. Background: Recent literature points to a…
  • 2019 International Congress

    Clinical and cognitive features of anxiety in Parkinson’s disease

    G. Carey, L. Defebvre, A. Moonen, A. Leentjens, K. Dujardin (Lille, France)

    Objective: To determine the demographic, clinical and cognitive features associated with anxiety disorders in Parkinson’s disease (PD). Background: The point prevalence of anxiety disorders in…
  • 2019 International Congress

    Factitious Disorder Imposed on Another mimicking a Dopamine Dysregulation Syndrome

    DRC. Carneiro, MS. Sousa, ASM. Morgadinho, CJ. Januário (Coimbra, Portugal)

    Objective: To present a new type of Dopamine Dysregulation Syndrome in Parkinson's Disease. Background: Dopamine Dysregulation Syndrome (DDS) is a rare neuropsychiatric complication of Parkinson’s…
  • 2019 International Congress

    Neuropsychiatric manifestations in Parkinson’s disease

    O. Cherkaoui Rhazouani, N. Jalami, M. Chraa, N. Kissani (Marrakech, Morocco)

    Objective: Evaluate the different neuropsychiatric manifestations in Parkinson's disease. Background: Parkinson's disease (PD) is the second most common neurodegenerative pathology after Alzheimer's disease, although PD…
  • 2019 International Congress

    Study of prevalence of Axis-1 DSM-4 psychiatric disorders in patients with parkinsonism in a rural movement disorder clinic in Western India

    D. Desai, S. Singh, S. Desai (Anand, India)

    Objective: To assess the prevalence of Axis-1 DSM-4 [The Diagnostic and Statistical Manual of Mental disorders] psychiatric disorders in patients with Parkinson’s disease [PD], atypical…
  • 2019 International Congress

    Progression of neuropsychiatric symptoms in Parkinson’s disease

    J. Dlay, G. Duncan, T. Khoo, C. Williams-Gray, D. Breen, R. Barker, D. Burn, R. Lawson, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the progression of neuropsychiatric symptoms (NPS) in Parkinson’s disease (PD) and their associations with quality of life (QoL) and motor problems. Background:…
  • 2019 International Congress

    Depression in Parkinson’s diseaese: Experience of the neurology department in Mohammed VI third level university hospital

    H. El Yachkouri, M. Chraa, N. Kissani (Marrakesh, Morocco)

    Objective: The objectives of this study are to evaluate the frequency of depression in our Parkinson's disease patients, to describe the relationship of depression to…
  • « Previous Page
  • 1
  • …
  • 1228
  • 1229
  • 1230
  • 1231
  • 1232
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley